TIS 0.00% 0.0¢ tissue therapies limited

Shoulda gone with VitroGro, page-11

  1. 529 Posts.
    lightbulb Created with Sketch. 58
    Didn't the MHRA play a significant role in delaying the CE Mark for Vitrogro for 2 years? Tends to confirm my earlier suspicions that a large pharma (in this case Smith and Nephew), with a similar product in the wings, applied pressure to get in ahead of us.

    Just my opinion so draw your own conclusions .......
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.